STERIS plc 10-Q

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES, USE OF PROCEEDS, AND ISSUER PURCHASES OF EQUITY SECURITIES On May 3, 2023 our Board of Directors terminated the previous share repurchase program then in effect and authorized a new share repurchase program for the purchase of up to $500 million (net of taxes, fees and commissions). As of September 30, 2023, we have not made any repurchases under this share repurchase program. This share repurchase program has no specified expiration date. Under the May 3, 2023 authorization, the Company may repurchase its shares from time to time through open market purchases, including 10b5-1 plans. Any share repurchases may be activated, suspended or discontinued at any time. During the first six months of fiscal 2024, we had no share repurchase activity pursuant to the previous share repurchase program or the May 3, 2023 authorization. This does not include 8 shares purchased during the quarter at an average price of $220.67 per share by the STERIS Corporation 401(k) Plan on behalf of an executive officer of the Company who may be deemed to be an affiliated purchaser. During the first six months of fiscal 2024, we obtained 57,161 of our ordinary shares in the aggregate amount of $9.2 million in connection with share-based compensation award programs. The following table summarizes the ordinary shares repurchase activity during the second quarter of fiscal 2024 under our ordinary share repurchase program: (dollars in thousands) Total Number of Shares Purchased Average Price Paid Per Share Total Number of Shares Purchased as Part of Publicly Announced Plans Maximum Dollar Value of Shares that May Yet Be Purchased Under the Plans at Period End (in thousands) July 1-31 — $ — — $ 500,000 August 1-31 — — — 500,000 September 1-30 — — — 500,000 Total — $ — — $ 500,000